Manufacturer record
SBS Biotech: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by SBS Biotech (Himachal Pradesh) were declared Not of Standard Quality between February 2025 and July 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NR/240715, Lorazepam Tablets IP (LORAT-1) (exp Dec 2026). State Drugs Laboratory, Punjab (state lab) found it not of standard quality: The Dissolution of Lorazepam does not complies within the prescribed limit of not less than Q value i.e 60% of labelled claim and 80% of. Listed in the July 2025 alert.
Records by type
2 records linked to SBS Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Lorazepam Tablets IP (LORAT-1) | Batch NR/240715Mfg Jul 2024 · Exp Dec 2026 | The Dissolution of Lorazepam does not complies within the prescribed limit of not less than Q value i.e 60% of labelled claim and 80% of labelled claim after 30 min. (45.09%) and after 60 min.(71.34%) respectively as stated in I.P 2022.Dissolution | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Haloperidol Injection IP (Radipace) | Batch L2403/2Mfg Mar 2024 · Exp Feb 2026 | Particulate matter and DescriptionDescription | CDL KolkataCDSCO lab | Feb 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.